Huabo Biopharm Co., Ltd.

Quick facts

Phase 3 pipeline

• HB0017 Q4W · Immunology
  HB0017 Q4W is a monoclonal antibody targeting a specific protein to modulate the immune system.
• HB0017 Q8W · Oncology
  HB0017 Q8W is a monoclonal antibody targeting the PD-1 receptor.
• HB0025 · Diabetes
  HB0025 is a small molecule that targets the SGLT2 receptor.

Phase 2 pipeline

• HB0017

Phase 1 pipeline

• HB002.1M
• HB002.1T
• HOT-1030

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Huabo Biopharm Co., Ltd. portfolio CI brief
• Huabo Biopharm Co., Ltd. pipeline updates RSS